Market Highlights
According to MRFR analysis, Antiemetics Market
is expected to register a CAGR of 6.6% during the forecast period of 2019
to 2025 and account for USD 6.7 Billion in 2025.
The Global Antiemetics Market is
expected to grow at a steady pace. There are numerous antiemetics agents
available for the treatment of nausea and vomiting, including; dopamine
antagonists, anticholinergics, antihistamines, serotonin antagonists, and others.
The key players manufacturing these products include GSK, Merck, and Pfizer
Inc. As these players generate their maximum revenue from the Americas for the
market, the region accounted for significant share across the globe.
The market is expected to grow at a
steady growth rate. The significant factors influencing the growth of the
market include increasing investment in the pharmaceutical industry, increasing
the number of postoperative procedures, pregnancy-induced nausea, and acute
gastroenteritis, further influencing the growth of the market. Moreover, the
rising demand for novel therapeutics and the increasing prevalence of
postoperative nausea and vomiting (PONV) is responsible for positive market
growth.
Segmentation
The Global Antiemetics Market has
been segmented into agents, drug type, application, and distribution channel.
By agents, the market has been
segmented into dopamine antagonists, anticholinergics, antihistamines,
serotonin antagonists, cannabinoids, and others. Furthermore, dopamine
antagonists is segmented into phenothiazines (chlorpromazine,
prochlorperazine), butyrophenones (droperidol, domperidone ), and benzamides.
Moreover, serotonin antagonists is further divided into ondansetron,
granisetron. The others segment includes dexamethasone and propofol. Dopamine
accounted for the largest market share majorly due to FDA approval for the
maximum number of application
By drug type, the market is
segmented into prescribed and OTC. Prescribed drugs accounted for the large
share by drugs type due to the high cost of the drugs when compared to OTC and
also are most prescribed by the professionals.
Based on application, the market is
segmented into chemotherapy, motion sickness, stomach flu, pregnancy,
postoperative surgery, and others. Postoperative surgery accounted for the
largest market share on the basis of attributing to an increasing number of
surgery procedures and mandatory postoperative procedures for the same.
The global antiemetics market, by
distribution channel, has been a retail pharmacy, hospital pharmacy, online. On
the basis of distribution channel, retail pharmacies accounted for the largest
share due to the presence of a large number of retail pharmacies across the
globe.
Key Players
Some of the key players
in the Global Antiemetics Market are GSK (UK), Merck (US), Sanofi-Aventis (France),
Pfizer Inc. (US), Mylan (US), Eli Lilly and Company (US), Johnson & Johnson
(US), Baxter International (US), Dr. Reddy's Laboratories Inc. (India) and
others.
Regional Analysis
On a regional basis, the Americas
are anticipated to dominate the global antiemetics market owing to the growing
clinical research & development budgets by both public and private
organizations in the pharmaceutical industry, increasing demand for novel
therapeutics and the abundant presence of significant manufacturer in the
region. Additionally, rising postoperative procedures is expected to influence
the growth of the market. According to a study, it is found that PONV occurs in
nearly 30% of the general surgical population and up to 70% to 80% of high-risk
surgical patients. Europe is expected to account for the second-largest market
in the global antiemetics market owing to well-developed research
infrastructure, increasing healthcare awareness in the region, and high
expenditure in pharmaceutical research.
Moreover, rising healthcare
expenditure is boosting the market in this region. Asia-Pacific is expected to
be the fastest-growing region due to the growing interest of major key players
in entering emerging markets, increasing development in the pharmaceutical
industry in this region. Moreover, increasing the adoption of chemotherapy for
the treatment of cancer expected to influence the growth of the market. The
Middle East & Africa is expected to account for the least share of the
global antiemetics market. Moreover, the significant market share of the region
is expected to be held by the Middle East region owing to the increasing
investment by major manufacturers and changing healthcare reforms.
No comments:
Post a Comment